U.S. Beverage Stock News

NYSE:BDC
NYSE:BDCElectronic

Assessing Belden (BDC) Valuation After Strong Recent Share Price Momentum

Without a specific news headline driving attention, Belden (BDC) is drawing interest as investors look at its recent share performance, business profile, and current financial footprint in data infrastructure and industrial connectivity. See our latest analysis for Belden. Belden’s share price has pulled back 2.7% over the last day but still sits at US$143.30 after a strong 30 day share price return of 21.95% and a 1 year total shareholder return of 30.46%, which points to momentum that has...
NasdaqCM:FMNB
NasdaqCM:FMNBBanks

How Investors May Respond To Farmers National Banc (FMNB) Margin Pressures And Rising Credit Risk Concerns

Farmers National Banc recently drew heightened attention as a regional lender with a traditional community banking model centered on Ohio and nearby Midwest markets, where it is contending with margin pressure from higher deposit costs and slower loan repricing. What makes this situation especially important is the combination of rising credit risks in commercial real estate and small business portfolios with questions about how regulatory scrutiny and the interest‑rate backdrop could affect...
NYSE:ESRT
NYSE:ESRTOffice REITs

A Look At Empire State Realty Trust’s Valuation After Earnings, New Leases And Buybacks

Why Empire State Realty Trust is back on investors’ radar Empire State Realty Trust (ESRT) has moved back into focus after fourth quarter 2025 results showed higher quarterly revenue and net income year over year, alongside fresh leasing wins with major tenants. For the fourth quarter, ESRT reported sales of US$159.72 million and revenue of US$199.22 million, compared with US$155.13 million and US$197.6 million a year earlier. Net income came in at US$20.73 million versus US$12.22 million,...
NasdaqGM:FLGT
NasdaqGM:FLGTHealthcare

Assessing Fulgent Genetics (FLGT) Valuation After Earnings Outperformance And AI Oncology Pipeline Progress

Fulgent Genetics (FLGT) is back on investors’ radar after its latest update, with 2025 earnings showing US$322.67 million in sales, a wider net loss, and fresh 2026 revenue guidance of about US$350 million. See our latest analysis for Fulgent Genetics. The share price reaction has been sharp, with a 1 day share price return of a 38.09% decline and a year to date share price return of a 40.09% decline, even though the 1 year total shareholder return is roughly flat. This suggests recent...
NYSE:NSA
NYSE:NSASpecialized REITs

Did NSA’s Strong Q4 Beat and 2026 EPS Guidance Just Shift National Storage Affiliates Trust's (NSA) Investment Narrative?

In February 2026, National Storage Affiliates Trust reported fourth-quarter 2025 results with revenue of US$187.03 million and net income of US$22.89 million, alongside full-year 2025 revenue of US$752.93 million and net income of US$73.78 million, and issued 2026 guidance that included diluted EPS of US$0.93 to US$1.03. Beyond the headline earnings beat, the company highlighted improving occupancy, sequential same-store revenue progress, and funds from operations above expectations, while...
NasdaqGS:SAFT
NasdaqGS:SAFTInsurance

Did Strong 2025 Results and Capital Returns Just Shift Safety Insurance Group's (SAFT) Investment Narrative?

Safety Insurance Group, Inc. reported past full-year 2025 results, with revenue of US$1,263.73 million and net income of US$99.26 million, alongside fourth-quarter net income of US$20.1 million on revenue of US$319.3 million. The company paired these stronger earnings with shareholder-focused actions, including repurchasing US$20 million of stock in the fourth quarter and approving a US$0.92 per-share quarterly dividend payable in March 2026. We’ll now examine how the combination of improved...
NYSE:DELL
NYSE:DELLTech

US Stock Market Today S&P 500 Futures Slide On Inflation And Geopolitical Jitters

The Morning Bull - US Market Morning Update Monday, Mar, 2 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 futures down about 1.3% and Nasdaq futures off roughly 1.7%, as investors react to a mix of higher costs and geopolitical tension. Government bond yields in Italy, Germany and the UK are higher, which means borrowing is getting more expensive just as Middle East tensions keep energy prices and inflation worries alive. At the same time, factory scorecards such...
NasdaqGM:ODD
NasdaqGM:ODDPersonal Products

Oddity Tech (ODD) Is Down 60.6% After Forecasting 30% Q1 2026 Revenue Decline - What's Changed

In February 2026, Oddity Tech reported fourth-quarter 2025 sales of US$152.73 million and net income of US$5.88 million, alongside full-year 2025 sales of US$809.84 million and net income of US$110.75 million, while completing a US$47 million buyback of 1,250,000 shares previously announced in June 2024. At the same time, management guided to an approximately 30% year-over-year revenue decline for the first quarter of 2026 due to higher acquisition costs, highlighting a short-term...
NYSE:KNTK
NYSE:KNTKOil and Gas

How Stronger EPS And Kings Landing Progress At Kinetik Holdings (KNTK) Has Changed Its Investment Story

Kinetik Holdings Inc. recently reported fourth-quarter 2025 revenue of US$430.42 million and net income of US$416.70 million, with full-year 2025 revenue of US$1.76 billion and net income of US$525.93 million, marking a sharp jump in earnings per share from continuing operations versus 2024. Alongside these results, Kinetik highlighted progress on projects such as the Kings Landing sour-gas conversion and the Barilla Draw acquisition, while outlining a 2026 “rebuilding” mandate focused on...
NYSE:POR
NYSE:PORElectric Utilities

Is Portland General Electric’s 2025 Results and US$480 Million Equity Raise Altering The Investment Case For Portland General Electric (POR)?

In February 2026, Portland General Electric reported full-year 2025 revenue of US$3,576 million and net income of US$306 million, while also disclosing lower earnings per share than the prior year. On the same day, the company completed a roughly US$480 million follow-on common stock offering, signaling a major capital raise that meaningfully alters its equity base and funding mix. We’ll now examine how this substantial equity issuance may influence Portland General Electric’s investment...
NasdaqCM:BLFS
NasdaqCM:BLFSLife Sciences

Does BioLife’s 2026 Profitability Guidance and Media Strength Change The Bull Case For BLFS?

In February 2026, BioLife Solutions, Inc. reported fourth-quarter 2025 sales of US$24.76 million, full-year 2025 sales of US$96.21 million, a reduced full-year net loss of US$4.60 million, and issued 2026 revenue guidance of US$112.5 million to US$115.0 million alongside an expectation of GAAP net income for the year. Management highlighted that growth was primarily driven by its biopreservation media franchise, now embedded in multiple approved cell and gene therapies, supported by a...
NYSE:HOUS
NYSE:HOUSReal Estate

Anywhere Real Estate (HOUS) Is Up 24.6% After Narrowing Annual Net Loss On Higher Revenue - What's Changed

Anywhere Real Estate Inc. has released its full-year 2025 results, reporting revenue of US$5,960 million compared with US$5,692 million in 2024, and a net loss of US$90 million versus US$128 million previously. The combination of higher revenue and a smaller net loss points to operational progress that investors may see as a sign of improving financial health, even though the business remains loss-making. We’ll now examine how this revenue growth and reduced net loss might reshape Anywhere...
NasdaqGS:LFST
NasdaqGS:LFSTHealthcare

What LifeStance Health Group (LFST)'s Profit Return, Buyback Plan, and Stock Offerings Mean For Shareholders

In late February 2026, LifeStance Health Group reported fourth-quarter 2025 revenue of US$382.2 million and net income of US$11.7 million, issued 2026 revenue guidance of US$1.615 billion to US$1.655 billion, authorized a US$100 million share repurchase plan, and filed follow-on and shelf registrations for new common stock offerings. Together, the return to profitability, expanded capital markets activity, and planned buybacks highlight how LifeStance is actively reshaping its balance...
NYSE:TFIN
NYSE:TFINBanks

Does Triumph Financial’s (TFIN) Steady Preferred Dividend Reveal Its True Capital Allocation Priorities?

In late February 2026, Triumph Financial, Inc.’s board declared a quarterly cash dividend of US$17.81 per share on its 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock, with holders of NYSE-listed depositary shares receiving US$0.44525 per share payable on March 30, 2026 to investors of record on March 15, 2026. This routine preferred dividend, alongside fresh inflation data that may influence Federal Reserve policy, highlights the contrast between Triumph’s capital return...
NYSE:ST
NYSE:STElectrical

Is Sensata Technologies (ST) Share Price Attractive After Mixed Multi Year Returns?

If you are wondering whether Sensata Technologies Holding's current share price reflects its true worth, you are not alone. Many investors are asking the same question. The stock last closed at US$37.34, with returns of 0.9% over 7 days, 8.0% over 30 days, 7.0% year to date and 38.8% over 1 year, while the 3 year and 5 year returns sit at 23.7% and 33.1% declines respectively. These mixed returns set the scene for a closer look at what recent developments might mean for the business and its...
NasdaqGS:SBGI
NasdaqGS:SBGIMedia

Assessing Sinclair (SBGI) Valuation After Recent Share Price Momentum

Why Sinclair Is On Investors’ Radar Right Now Sinclair (SBGI) has drawn attention after recent share price moves, with the stock around $16.34 and showing double digit returns over the past month and past three months, prompting fresh interest in its current valuation. See our latest analysis for Sinclair. The recent momentum, with a 7 day share price return of 11.92% and 30 day share price return of 12.61% at a current share price of $16.34, sits alongside a 1 year total shareholder return...
NYSE:ALLE
NYSE:ALLEBuilding

Schlage Aspect Collection Launch Adds New Angle To Allegion Growth Story

Schlage, part of Allegion, has launched the Aspect Collection of interior door hardware, focused on bold design and easier installation. The collection expands Allegion's design centric portfolio and targets homeowners and professionals looking for more modern style options. The announcement highlights Allegion's emphasis on combining aesthetics with everyday usability in its residential product lineup. For investors watching Allegion (NYSE:ALLE), the Aspect Collection lands at a time when...
NYSE:PSN
NYSE:PSNProfessional Services

Bastion’s Parsons Bet Highlights Tension Between Volatile Trading And Long Term Themes

Bastion Asset Management has opened a significant new equity position in Parsons (NYSE:PSN). The holding ranks as a substantial position within Bastion’s portfolio. The move adds a new institutional holder to Parsons, which focuses on government and critical infrastructure projects. Parsons, traded on the NYSE under the ticker PSN, works across defense, intelligence, and critical infrastructure, areas that often rely on long term federal and public sector contracts. For investors watching...
NYSE:CVSA
NYSE:CVSAConsumer Services

Covista Rebrand Pairs New Ticker With Three Year Growth Targets

Covista Inc., formerly Adtalem Global Education Inc., has completed a full corporate rebrand and name change. The company has also updated its ticker symbol to NYSE:CVSA. Alongside the rebrand, Covista introduced a three year growth plan targeting the U.S. healthcare workforce shortage. Covista operates in healthcare education, a segment that sits at the center of ongoing shortages across many clinical roles in the U.S. The company is presenting its new identity and plan as a response to...
NYSE:RBRK
NYSE:RBRKSoftware

Rubrik’s Growth Story Weighs Market Share Potential Against Ongoing Losses

Rubrik (NYSE:RBRK) is drawing fresh attention as recent updates highlight strong revenue gains, high net retention, and solid margins. The company reports operating with a very low share of its target market, which points to meaningful room for further enterprise cybersecurity adoption. Management continues to emphasize Rubrik’s subscription-based model and high switching costs as key supports for its position in data security. At a share price of $51.96, NYSE:RBRK sits against a backdrop...
NasdaqGS:DAWN
NasdaqGS:DAWNBiotechs

Does Day One Biopharmaceuticals (DAWN) Share Price Reflect Its Oncology Pipeline Prospects?

If you are wondering whether Day One Biopharmaceuticals' current share price lines up with its underlying worth, you are not alone. The stock most recently closed at US$10.60, with a 7 day return of 10% decline, a 30 day return of 5% decline, gains of 19.8% year to date and 17% over the past year, while the 3 year return sits at 43.4% decline. Recent news around Day One has largely focused on its development stage oncology pipeline and ongoing progress in clinical programs, which can...
NasdaqGS:DHC
NasdaqGS:DHCHealth Care REITs

A Look At Diversified Healthcare Trust (DHC) Valuation After Earnings Reveal Narrower Net Loss

What the latest earnings tell you about Diversified Healthcare Trust Diversified Healthcare Trust (DHC) has just reported fourth quarter and full year 2025 results, showing lower quarterly sales but a narrower net loss, a combination that naturally puts the stock back on investors’ radar. See our latest analysis for Diversified Healthcare Trust. That earnings update landed after a strong run in the shares, with a 90 day share price return of 39.96% and a year to date share price return of...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

A Look At MannKind (MNKD) Valuation After New United Therapeutics Inhaler Raises Royalty Concerns

MannKind (MNKD) is back in focus after partner United Therapeutics introduced a soft mist inhaler designed to compete with Tyvaso DPI, raising fresh questions around MannKind’s future royalty stream and overall risk profile. See our latest analysis for MannKind. The stock’s 7 day share price return of 40.79% and 30 day share price return of 43.25% follow earnings that paired higher revenue with a quarterly loss, while the United Therapeutics soft mist inhaler news sharply reset sentiment...
NasdaqGS:KALU
NasdaqGS:KALUMetals and Mining

Is Kaiser Aluminum (KALU) Still Attractive After A 90% One-Year Share Price Surge?

If you are wondering whether Kaiser Aluminum's current share price lines up with its underlying worth, this article walks through the key signals you will want to weigh. The stock last closed at US$130.14, with returns of 0.9% over 7 days, 6.1% over 30 days, 8.2% year to date, 90.5% over 1 year, 74.0% over 3 years, and 36.6% over 5 years. This performance sets an important backdrop for any value check. Recent coverage around Kaiser Aluminum has focused on how investors view its role within...